News
VRXAW
0.1687
0.00%
0.00
Veraxa Biotech advances VXA-222 following milestone in OmniAb pact
TipRanks · 6h ago
VERAXA Biotech Advances Bispecific ADC VXA‑222 With OmniAb Milestone, Moving Alliance Into Next Phase Of Cancer Therapy Discovery
Benzinga · 6h ago
Weekly Report: what happened at VRXA last week (0720-0724)?
Weekly Report · 6h ago
Veraxa Biotech shareholders approved all proposals at extraordinary general meeting
PUBT · 2d ago
VERAXA BIOTECH SHAREHOLDERS APPROVE ALL PROPOSALS AT EXTRAORDINARY GENERAL MEETING, STRENGTHENING STRATEGIC FLEXIBILITY FOR FUTURE GROWTH
Reuters · 2d ago
VERAXA Biotech AG (NASDAQ: VRXA) Appoints Christoph Erkel as Chief Scientific Officer
TipRanks · 3d ago
VERAXA Biotech (NASDAQ: VRXA) Advances BiTAC(R)-TCE Development with Positive Regulatory Feedback from Germany
TipRanks · 4d ago
Veraxa Biotech names Christoph Erkel chief scientific officer, succeeding Rick Austin
PUBT · 4d ago
VERAXA Biotech (NASDAQ: VRXA) Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
TipRanks · 07/20 17:00
VERAXA Gets German Regulatory Feedback On Cancer Therapy Plan
Benzinga · 07/20 11:09
Veraxa Biotech notifies availability of press release on BiTAC-TCE regulatory progress
PUBT · 07/20 11:02
Veraxa Biotech receives PEI scientific advice on BiTAC-TCE development plan
PUBT · 07/20 11:01
Weekly Report: what happened at VRXA last week (0713-0717)?
Weekly Report · 07/20 10:34
VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
Barchart · 07/20 06:00
Why VERAXA Biotech (NASDAQ: VRXA) Could Benefit More Than Others From AI’s Growing Impact on Drug R&D 
TipRanks · 07/15 17:30
VERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development
TipRanks · 07/13 17:30
Veraxa Biotech announces BiTAC pipeline collaboration with Ardigen
TipRanks · 07/13 11:25
VERAXA Biotech Partners With AI-Driven Computational R&D Partner Ardigen To Support Its Growing BiTAC Pipeline Of T Cell Engagers And Antibody Drug Conjugates
Benzinga · 07/13 11:08
Veraxa Biotech partners with Ardigen on AI-enabled drug discovery for BiTAC pipeline
PUBT · 07/13 11:00
VERAXA BIOTECH TO LAUNCH AI-ENABLED DRUG DISCOVERY COLLABORATION WITH ARDIGEN TO SUPPORT GROWING BITAC® PIPELINE
Reuters · 07/13 11:00
More
Webull provides a variety of real-time VRXAW stock news. You can receive the latest news about Veraxa Biotech AG through multiple platforms. This information may help you make smarter investment decisions.